BlackRock Inc. - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 198 filers reported holding ROYALTY PHARMA PLC in Q4 2020. The put-call ratio across all filers is 2.07 and the average weighting 1.8%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$558,103,004
-12.5%
20,563,854
-0.9%
0.02%
-11.1%
Q2 2023$637,594,299
-10.8%
20,741,519
+4.5%
0.02%
-14.3%
Q1 2023$715,153,783
-6.8%
19,848,842
+2.2%
0.02%
-12.5%
Q4 2022$767,211,684
+4.5%
19,413,251
+6.3%
0.02%
-4.0%
Q3 2022$734,092,000
-5.1%
18,270,089
-0.7%
0.02%0.0%
Q2 2022$773,439,000
+13.5%
18,397,640
+5.2%
0.02%
+38.9%
Q1 2022$681,145,000
+2.3%
17,483,188
+4.6%
0.02%
+5.9%
Q4 2021$666,107,000
+19.2%
16,715,324
+8.1%
0.02%
+6.2%
Q3 2021$558,754,000
+32.5%
15,460,845
+50.3%
0.02%
+33.3%
Q2 2021$421,691,000
-29.3%
10,287,641
-24.7%
0.01%
-33.3%
Q1 2021$596,048,000
+31.5%
13,664,581
+50.9%
0.02%
+28.6%
Q4 2020$453,128,000
+188.6%
9,053,545
+142.6%
0.01%
+133.3%
Q3 2020$156,989,000
+57.7%
3,731,632
+82.0%
0.01%
+50.0%
Q2 2020$99,534,0002,050,1450.00%
Other shareholders
ROYALTY PHARMA PLC shareholders Q4 2020
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 6,761,970$338,436,00092.73%
Vantage Consulting Group Inc 21,477,282$1,074,938,00087.53%
Memorial Sloan Kettering Cancer Center 3,565,887$178,473,00075.56%
HARVARD MANAGEMENT CO INC 14,690,780$735,274,00039.88%
ROBERT WOOD JOHNSON FOUNDATION 3,958,498$1,981,228,00021.69%
Brown University 381,759$19,107,00013.82%
Overbrook Management Corp 778,511$38,964,0009.50%
ADAGE CAPITAL PARTNERS GP, L.L.C. 38,714,280$1,937,650,0004.22%
Lagoda Investment Management, L.P. 96,885$4,849,0002.61%
HealthCor Management, L.P. 1,339,530$67,043,0002.58%
View complete list of ROYALTY PHARMA PLC shareholders